These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9222488)

  • 1. The skeletal effects of primary hyperparathyroidism.
    Grey AB
    Baillieres Clin Endocrinol Metab; 1997 Apr; 11(1):101-16. PubMed ID: 9222488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary hyperparathyroidism: lessons from bone histomorphometry.
    Eriksen EF
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N95-7. PubMed ID: 12412784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hyperparathyroidism and the skeleton.
    Mosekilde L
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):1-19. PubMed ID: 18167138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone densitometry: patients with asymptomatic primary hyperparathyroidism part I. Technical report.
    Erlichman M; Holohan TV
    Health Technol Assess (Rockv); 1995 Dec; (6):1-30. PubMed ID: 8938232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phalangeal quantitative ultrasound technology and dual energy X-ray densitometry in patients with primary hyperparathyroidism: influence of sex and menopausal status.
    Camozzi V; Lumachi F; Mantero F; Piccolo M; Luisetto G
    Osteoporos Int; 2003 Jul; 14(7):602-8. PubMed ID: 12730752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis.
    Sankaran S; Gamble G; Bolland M; Reid IR; Grey A
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1653-62. PubMed ID: 20130069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism.
    Kaji H; Yamauchi M; Chihara K; Sugimoto T
    Eur J Endocrinol; 2005 Sep; 153(3):373-8. PubMed ID: 16131599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
    Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal effects of primary hyperparathyroidism: bone mineral density and fracture risk.
    Lewiecki EM; Miller PD
    J Clin Densitom; 2013; 16(1):28-32. PubMed ID: 23374738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary hyperparathyroidism: whole-body bone mineral density in surgically treated Danish patients: a three-year follow-up study.
    Christiansen P; Steiniche T; Brixen K; Hessov I; Melsen F; Heickendorff L; Mosekilde L
    Bone; 1999 Nov; 25(5):597-602. PubMed ID: 10574581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal damage?
    Carnevale V; Manfredi G; Romagnoli E; De Geronimo S; Paglia F; Pepe J; Scillitani A; D'Erasmo E; Minisola S
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):81-6. PubMed ID: 14678292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated bone loss in post-menopausal women with mild primary hyperparathyroidism.
    Grey AB; Stapleton JP; Evans MC; Reid IR
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):697-702. PubMed ID: 8759182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of osteopenia secondary to primary hyperparathyroidism.
    Yamaguchi T; Sugimoto T; Chihara K
    Biomed Pharmacother; 2000 Jun; 54 Suppl 1():104s-107s. PubMed ID: 10915004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year longitudinal changes in forearm cortical bone geometry in postmenopausal women with mild primary hyperparathyroidism without parathyroidectomy.
    Kaji H; Yamauchi M; Nomura R; Sugimoto T
    Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):633-6. PubMed ID: 19053030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased cortical and increased cancellous bone in two children with primary hyperparathyroidism.
    Boechat MI; Westra SJ; Van Dop C; Kaufman F; Gilsanz V; Roe TF
    Metabolism; 1996 Jan; 45(1):76-81. PubMed ID: 8544781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of skeletal health in patients with asymptomatic primary hyperparathyroidism.
    Lewiecki EM
    J Clin Densitom; 2010; 13(4):324-34. PubMed ID: 21029971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.
    Grey AB; Stapleton JP; Evans MC; Tatnell MA; Reid IR
    Ann Intern Med; 1996 Sep; 125(5):360-8. PubMed ID: 8702086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation of bone mass determinations as they relate to fracture: implications for asymptomatic primary hyperparathyroidism.
    Peacock M
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S77-82; discussion S83-4. PubMed ID: 1763673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism.
    Hagström E; Lundgren E; Mallmin H; Rastad J; Hellman P
    J Intern Med; 2006 Feb; 259(2):191-8. PubMed ID: 16420548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.